Pirfenidone: A novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis

被引：18
|
作者：
Dosanjh, AK [1 ]
Wan, B [1 ]
Throndset, W [1 ]
Sherwood, S [1 ]
Morris, RE [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(98)00478-3
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1910 / 1911
页数：2
相关论文
共 50 条
  • [31] Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation
    Chacon, RA
    Corris, PA
    Dark, JH
    Gibson, GJ
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (03): : 263 - 269
  • [32] CHARACTERIZING THE ROLE OF PIMOZIDE AS A NOVEL ANTIFIBROTIC AGENT IN HEPATIC FIBROGENESIS
    Shihan, Mahbubul
    Yu, Amy
    Chen, Jennifer Y.
    HEPATOLOGY, 2021, 74 : 806A - 806A
  • [33] Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in rats and beagle dogs following oral and intravenous administration
    Wu, Jianhong
    Wu, Ji
    Chen, Hui
    Zeng, Fandian
    Zou, Sunchang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 213 - 214
  • [34] THE EFFECTS OF ANTIFIBROTIC AGENT-PIRFENIDONE ON PENILE CAVERNOUS FUNCTION IN EXPERIMENTAL ISCHAEMIC PRIAPISM-INDUCED RAT MODEL
    Cinar, O.
    Bolat, M. S.
    Erdem, S.
    Kaymaz, E.
    Demirkiran, E. D.
    Girgin, R.
    Bulut, E.
    Akduman, B.
    Mungan, N. A.
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (05): : S31 - S31
  • [35] Pirfenidone: A novel potential therapeutic agent in the management of chronic allograft rejection
    Dosanjh, A.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2153 - 2156
  • [36] PIRFENIDONE - A NOVEL PHARMACOLOGICAL AGENT FOR PREVENTION AND RESOLUTION (REMOVAL) OF LUNG FIBROSIS
    MARGOLIN, SB
    LEFKOWITZ, S
    FASEB JOURNAL, 1994, 8 (04): : A382 - A382
  • [37] Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
    Haack, Katrin Esther Hostettler
    Halter, Jorg
    Tamm, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [38] Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation
    Shu, Ping
    Zhang, Wei
    Zhang, Yanfei
    Zhao, Yanfeng
    Li, Yuping
    Zhang, Xiaoqing
    DISEASE MARKERS, 2021, 2021
  • [39] Anti-fibrotic treatment with pirfenidone in patients with GvHD-associated bronchiolitis obliterans syndrome
    Hostettler, K. E.
    Gerull, S.
    Nair, G.
    Passweg, J.
    Tamm, M.
    Halter, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S200 - S200
  • [40] Pirfenidone: A novel hypothetical treatment for COVID-19
    Seifirad, Soroush
    MEDICAL HYPOTHESES, 2020, 144
12345